Science Explorer Back to mapMap
Discussion
Company · Ahmedabad · India

Intas Pharmaceuticals (India)

intaspharma.comROR OpenAlex
World rank, all time
#31,596
of 34,923
Rank in India
#1,526
of 1,754
Research works
141
▲ 46% vs 2018-21
Citations
1.4k
9.6 per fractional work
Top-10% rate
4.4%
all institutions 10.0%
vs its own fields
0.93×
1.00× is exactly expected
Open access
54%
world 40%
International
14%
world 18%
Intas Pharmaceuticals (India)

Which fields of science does Intas Pharmaceuticals (India) work in?

In 2022-now, 55% of research at Intas Pharmaceuticals (India) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (5%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 34 fractional works · 55.3% of its workMedicine: 32 fractional works · 51.8% of its workOncology: 4 fractional works · 6.8% of its workEpidemiology: 2 fractional works · 3.6% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 3.5% of its workInfectious Diseases: 2 fractional works · 3.4% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 3.1% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.0% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.9% of its workSurgery: 2 fractional works · 2.7% of its workHematology: 1 fractional works · 2.4% of its workPharmacology: 1 fractional works · 2.2% of its workGenetics: 1 fractional works · 1.7% of its workGastroenterology: 1 fractional works · 1.6% of its workRheumatology: 1 fractional works · 1.6% of its workTransplantation: 1 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workNeurology: 1 fractional works · 1.2% of its workOrthopedics and Sports Medicine: 1 fractional works · 1.1% of its workReproductive Medicine: 1 fractional works · 0.9% of its workOphthalmology: 1 fractional works · 0.9% of its workUrology: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.8% of its workObstetrics and Gynecology: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.5% of its workHealth Informatics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 1 fractional works · 2.0% of its workSpeech and Hearing: 0 fractional works · 0.7% of its workEmergency Medical Services: 0 fractional works · 0.5% of its workPharmacy: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 1.5% of its workNutrition and Dietetics: 1 fractional works · 1.5% of its workLife Sciences: 15 fractional works · 24.9% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 13.6% of its workMolecular Biology: 6 fractional works · 9.3% of its workCancer Research: 1 fractional works · 1.6% of its workGenetics: 1 fractional works · 0.9% of its workBiochemistry: 0 fractional works · 0.8% of its workBiophysics: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 3 fractional works · 4.6% of its workImmunology: 3 fractional works · 4.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 4.1% of its workPharmaceutical Science: 2 fractional works · 2.9% of its workPharmacology: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.0% of its workCognitive Neuroscience: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workFood Science: 0 fractional works · 0.3% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.3% of its workPhysical Sciences: 8 fractional works · 12.7% of its workChemistry: 2 fractional works · 3.6% of its workAnalytical Chemistry: 1 fractional works · 2.1% of its workSpectroscopy: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workElectrochemistry: 0 fractional works · 0.3% of its workMaterials Science: 2 fractional works · 2.9% of its workBiomaterials: 1 fractional works · 1.8% of its workMaterials Chemistry: 1 fractional works · 1.1% of its workEngineering: 1 fractional works · 2.1% of its workBiomedical Engineering: 1 fractional works · 1.3% of its workComputational Mechanics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workComputer Science: 1 fractional works · 1.9% of its workComputational Theory and Mathematics: 1 fractional works · 1.6% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workMathematics: 1 fractional works · 1.1% of its workStatistics and Probability: 1 fractional works · 1.1% of its workEnvironmental Science: 1 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.1% of its workSocial Sciences: 4 fractional works · 7.1% of its workDecision Sciences: 2 fractional works · 2.9% of its workStatistics, Probability and Uncertainty: 2 fractional works · 2.4% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workManagement Science and Operations Research: 0 fractional works · 0.2% of its workPsychology: 1 fractional works · 1.6% of its workSocial Psychology: 1 fractional works · 1.6% of its workBusiness, Management and Accounting: 1 fractional works · 1.6% of its workStrategy and Management: 0 fractional works · 0.8% of its workManagement of Technology and Innovation: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.0% of its workEconomics and Econometrics: 1 fractional works · 1.0% of its workALL ITS WORKIntasPharmaceuticals…62fractional works, 2022-now
Life Sciences25%Physical Sciences13%Health Sciences55%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine3251.8%
    2. Health Professions12.0%
    3. Nursing11.5%
    1. Biochemistry, Genetics and Molecular Biology813.6%
    2. Immunology and Microbiology34.6%
    3. Pharmacology, Toxicology and Pharmaceutics34.1%
    4. Neuroscience11.6%
    5. Agricultural and Biological Sciences10.9%
    1. Chemistry23.6%
    2. Materials Science22.9%
    3. Engineering12.1%
    4. Computer Science11.9%
    5. Mathematics11.1%
    6. Environmental Science10.9%
    7. Chemical Engineering00.1%
    1. Decision Sciences22.9%
    2. Psychology11.6%
    3. Business, Management and Accounting11.6%
    4. Economics, Econometrics and Finance11.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.56× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 4.61× its world share, 3 worksImmunology and Micro…Neuroscience: 1.00× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.67× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.39× its world share, 0 worksChemical EngineeringChemistry: 2.31× its world share, 2 worksChemistryComputer Science: 0.24× its world share, 1 worksComputer ScienceEngineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.18× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.83× its world share, 2 worksMaterials ScienceMathematics: 0.96× its world share, 1 worksMathematicsHealth Professions: 0.77× its world share, 1 worksHealth ProfessionsMedicine: 2.70× its world share, 32 worksMedicineNursing: 3.03× its world share, 1 worksNursingBusiness, Management and Accounting: 0.49× its world share, 1 worksBusiness, Management…Decision Sciences: 3.03× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 0.45× its world share, 1 worksEconomics, Econometr…Psychology: 0.53× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.7×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics11.67×2 works
  2. Immunology and Microbiology4.61×3 works
  3. Nursing3.03×1 works
  4. Decision Sciences3.03×2 works
  5. Medicine2.70×32 works
  6. Biochemistry, Genetics and Molecular Biology2.56×8 works
  7. Chemistry2.31×2 works
  8. Neuroscience1.00×1 works
  9. Mathematics0.96×1 works
  10. Materials Science0.83×2 works
  11. Health Professions0.77×1 works
  12. Psychology0.53×1 works
  13. Business, Management and Accounting0.49×1 works
  14. Economics, Econometrics and Finance0.45×1 works
  15. Chemical Engineering0.39×0 works
  16. Computer Science0.24×1 works
  17. Agricultural and Biological Sciences0.18×0 works
  18. Environmental Science0.18×1 works
  19. Engineering0.14×1 works

Who are the top researchers at Intas Pharmaceuticals (India)?

Ranked on the quality score, Rikin V. Patel, Imran Ahmad and Ronak B. Patel lead among researchers whose main affiliation is Intas Pharmaceuticals (India).

  1. 1 Rikin V. Patel India · #2,936,366 worldwide 343 citations · 30 works
  2. 2 Imran Ahmad India · #3,391,372 worldwide 460 citations · 44 works
  3. 3 Ronak B. Patel India · #3,836,515 worldwide 985 citations · 79 works
  4. 4 Shashikant Sharma India · #4,207,416 worldwide 421 citations · 29 works
  5. 5 Mahesh Paithankar India · #4,405,970 worldwide 159 citations · 15 works
  6. 6 Shoukath M. Ali India · #4,700,966 worldwide 715 citations · 45 works
  7. 7 Anil Rajani India · #4,805,068 worldwide 50 citations · 17 works
  8. 8 Saifuddin Sheikh India · #4,953,846 worldwide 1k citations · 56 works
  9. 9 Jay Kumar Sharma India · #5,042,592 worldwide 28 citations · 17 works
  10. 10 Nisarg Joshi India · #5,076,247 worldwide 112 citations · 20 works
All ranked researchers at Intas Pharmaceuticals (India)

What are the most cited papers from Intas Pharmaceuticals (India)?

The most cited paper from Intas Pharmaceuticals (India) is "Ferroptosis of tumour neutrophils causes immune suppression in cancer" (Rina Kim et al., 2022), with 563 citations. Next come "A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate" (193) and "The H1 lead/scintillating-fibre calorimeter" (178).

Most cited papers
#PaperReleasedCitations
1 Ferroptosis of tumour neutrophils causes immune suppression in cancer Rina Kim et al. · Nature Open access 16 Nov 2022 563
2 A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate Lorena Sánchez-Felipe et al. · Nature Open access Dec 2020 193
3 The H1 lead/scintillating-fibre calorimeter R.D. Appuhn et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment Feb 1997 178
4 Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic®P85, anin vitrocell line andin vivobiodistribution studies on rat model Neha B. Shah, Kiran Chaudhari, Prudhviraju Dantuluri et al. · Journal of drug targeting 16 Jun 2009 110
5 Horsepower with Brains: The Design of the CHIRON Free Piston Engine Peter A. J. Achten, Johan P. J. Van Den Oever, Jeroen Potma et al. · SAE technical papers on CD-ROM/SAE technical paper series Conference paper 11 Sep 2000 105
All 62 most cited papers, with filters and sorting

Which keywords describe research at Intas Pharmaceuticals (India)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Monoclonal Antibodies, Biopharmaceuticals, Immunogenicity, Clinical Trials, Epidemiology, Clinical Outcomes, Cardiovascular Disease and Therapeutic Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 2.1×19 topics
  2. Monoclonal Antibodies4▲ 77×3 topics
  3. Biopharmaceuticals4▲ 121×2 topics
  4. Immunogenicity4▲ 145×2 topics
  5. Cardiovascular Disease3▲ 4.4×9 topics
  6. Clinical Trials3▲ 7.6×12 topics
  7. Inflammation3▲ 2.0×11 topics
  8. Clinical Outcomes2▲ 18×2 topics
  9. Chemotherapy2▲ 5.0×9 topics
  10. Depression2▲ 4.0×6 topics
  11. Therapeutic Antibodies2▲ 52×2 topics
  12. Bioanalytical Methods2▲ 165×1 topic
  13. Biosimilars2▲ 165×1 topic
  14. Drug Delivery2▲ 5.5×5 topics
  15. Stability2▲ 14×2 topics
  16. Protein Aggregation2▲ 55×1 topic
  17. Recombinant Proteins2▲ 93×1 topic
  18. Global Burden2▲ 5.0×4 topics
  19. Gene Therapy2▲ 13×4 topics
  20. Glycosylation2▲ 24×3 topics
  21. Heart Failure2▲ 5.7×6 topics
  22. Prophylaxis2▲ 21×2 topics
  23. SARS-CoV-22▲ 8.5×4 topics
  24. Bayesian Networks2▲ 26×1 topic
  25. Fault Tree Analysis2▲ 52×1 topic
  26. Monoclonal Antibody2▲ 43×2 topics
  27. ACE2 Receptor1▲ 10×3 topics
  28. Breast Cancer1▲ 8.7×5 topics
  29. Diabetes1▲ 4.7×4 topics
  30. Method Validation1▲ 42×2 topics
  31. Pharmacokinetics1▲ 8.5×2 topics
  32. Probiotics1▲ 9.3×3 topics
  33. Prostate Cancer1▲ 17×3 topics
  34. Cancer Treatment1▲ 8.7×4 topics
  35. Green Analytical Chemistry1▲ 37×1 topic
  36. Pharmaceutical Analysis1▲ 115×1 topic
  37. Genetic Variants1▲ 11×2 topics
  38. Health Services1▲ 21×2 topics
  39. Metastatic Breast Cancer1▲ 32×2 topics
  40. Microbiota1▲ 8.6×3 topics

Which research topics does Intas Pharmaceuticals (India) publish most on?

By volume in 2022-now: Biosimilars and Bioanalytical Methods, Protein purification and stability, Risk and Safety Analysis and Analytical Methods in Pharmaceuticals.

Biosimilars and Bioanaly…2Biosimilars and Bioanalytical Methods: 2 fractional worksProtein purification and…2Protein purification and stability: 2 fractional worksRisk and Safety Analysis2Risk and Safety Analysis: 2 fractional worksAnalytical Methods in Ph…1Analytical Methods in Pharmaceuticals: 1 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksDrug Solubulity and Delivery Systems: 1 fractional worksCancer Treatment and Pha…1Cancer Treatment and Pharmacology: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksGastrointestinal motility and disorders: 1 fractional worksBiotechnology and Relate…1Biotechnology and Related Fields: 1 fractional works
ImmunologyMolecular BiologyStatistics, Probability and UncertaintyAnalytical Chemistry5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biosimilars and Bioanalytical Methods Immunology 2 works
  2. 2 Protein purification and stability Molecular Biology 2 works
  3. 3 Risk and Safety Analysis Statistics, Probability and Uncertainty 2 works
  4. 4 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
  5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  6. 6 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
  7. 7 Cancer Treatment and Pharmacology Oncology 1 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  9. 9 Gastrointestinal motility and disorders Gastroenterology 1 works
  10. 10 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.0%not open46.0%

World: 40% of research is openly available.

with international co-authors14.5%domestic only85.5%

World: 18% is written across borders.

How has Intas Pharmaceuticals (India)'s research output changed?

Output in 2022-2025 was 46% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Intas Pharmaceuticals (India) as a percentage of every work published that year, 0.00015% in 2024.

still counting0.00020%0.00040%Intas Pharmaceuticals (India)0.00020% in 2025200020102020

Fractional works of Intas Pharmaceuticals (India) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ahmedabad

All research institutions in Ahmedabad

Share Intas Pharmaceuticals (India)'s ranking

Intas Pharmaceuticals (India) on Science Explorer

A card with Intas Pharmaceuticals (India)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Intas Pharmaceuticals (India). Posts are plain text and can be reported.